share_log

Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25

Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25

麦格理启动了对Privia Health Gr的覆盖,给予其优于大盘的评级,并宣布目标价为25美元。
Benzinga ·  12/16 21:37  · 评级/大行评级

Macquarie analyst Tao Qiu initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price Target of $25.

麦格理的分析师裘涛对Privia Health Gr(纳斯达克:PRVA)首次覆盖,给予超越市场表现评级,并发布25美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发